Frank Louis Jaksch Jr.
Net Worth

Last updated:

What is Frank Louis Jaksch Jr. net worth?

The estimated net worth of Mr. Frank Louis Jaksch Jr. is at least $11,804,234 as of 13 Dec 2024. He owns shares worth $1,925,547 as insider, has earned $992,387 from insider trading and has received compensation worth at least $8,886,300 in ChromaDex Corporation.

What is the salary of Frank Louis Jaksch Jr.?

Mr. Frank Louis Jaksch Jr. salary is $592,420 per year as Co-Founder & Executive Chairman in ChromaDex Corporation.

How old is Frank Louis Jaksch Jr.?

Mr. Frank Louis Jaksch Jr. is 57 years old, born in 1968.

What stocks does Frank Louis Jaksch Jr. currently own?

As insider, Mr. Frank Louis Jaksch Jr. owns shares in one company:

Company Title Shares Price per share Total value
ChromaDex Corporation (CDXC) Co-Founder & Executive Chairman 244,179 $7.89 $1,925,547

What does ChromaDex Corporation do?

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Frank Louis Jaksch Jr. insider trading

ChromaDex Corporation

Mr. Frank Louis Jaksch Jr. has made 8 insider trades between 2010-2024, according to the Form 4 filled with the SEC. Most recently he sold 37,161 units of CDXC stock worth $229,952 on 13 Dec 2024.

The largest trade he's ever made was exercising 66,665 units of CDXC stock on 10 Feb 2012. As of 13 Dec 2024 he still owns at least 244,179 units of CDXC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 37,161 $6.19 $229,952
Option
Employee Stock Options (right to buy) 50,001 $3.66 $183,004
Option
Common Stock 50,001 $3.66 $183,004
Purchase
Common Stock 7,000 $1.69 $11,830
Option
Common Stock 41,667 $4.62 $192,502
Sale
Common Stock 37,829 $5.19 $196,333
Option
Employee Stock Options (right to buy) 41,667 $4.62 $192,502
Option
Employee Stock Options (right to buy) 33,334 $1.5 $50,001
Option
Common Stock 33,334 $1.5 $50,001
Sale
Common Stock 14,390 $3.5 $50,365
Purchase
Common Stock 4,300 $3.56 $15,308
Purchase
Common Stock 5,500 $3.61 $19,855
Option
Common Stock 474 $4.5 $2,133
Option
Employee Stock Options (right to buy) 474 $4.5 $2,133
Sale
Common Stock 474 $4.5 $2,133
Option
Employee Stock Options (right to buy) 24,578 $4.5 $110,601
Option
Common Stock 24,578 $4.5 $110,601
Sale
Common Stock 24,578 $4.5 $110,601
Option
Employee Stock Options (right to buy) 6,249 $6.5 $40,619
Sale
Common Stock 6,249 $6.5 $40,619
Option
Common Stock 6,249 $6.5 $40,619
Option
Common Stock 22,130 $4.5 $99,585
Option
Employee Stock Options (right to buy) 22,130 $4.5 $99,585
Sale
Common Stock 22,130 $4.5 $99,585
Option
Employee Stock Options (right to buy) 58,400 $4.5 $262,800
Option
Common Stock 58,400 $4.5 $262,800
Sale
Common Stock 58,400 $4.5 $262,800
Purchase
Common Stock 2,000 $2.42 $4,840
Purchase
Common Stock 1,500 $3.32 $4,980
Purchase
Common Stock 5,000 $1.16 $5,800
Purchase
Common Stock 5,000 $0.72 $3,600
Purchase
Common Stock 5,000 $0.54 $2,700
Purchase
Common Stock 66,665 $0.75 $49,999
Purchase
Common Stock 7,500 $0.6 $4,500
Purchase
Common Stock 5,000 $1.5 $7,500

ChromaDex key executives

ChromaDex Corporation executives and other stock owners filed with the SEC: